BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36099091)

  • 1. TNF-α Indicates Radiation-induced Liver Injury After Interstitial High Dose-rate Brachytherapy.
    Damm R; Pech M; Haag F; Cavalli P; Gylstorff S; Omari J; Seidensticker R; Ricke J; Seidensticker M; Relja B
    In Vivo; 2022; 36(5):2265-2274. PubMed ID: 36099091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of chemokines and growth factors with radiation-induced liver injury after interstitial high dose rate (HDR) brachytherapy of liver metastases.
    Damm R; Pech M; Cavalli P; Haag F; Gylstorff S; Omari J; Thormann M; Seidensticker R; Ricke J; Seidensticker M; Relja B
    J Cancer Res Clin Oncol; 2022 Oct; 148(10):2815-2826. PubMed ID: 35596772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicity.
    Seidensticker M; Seidensticker R; Damm R; Mohnike K; Pech M; Sangro B; Hass P; Wust P; Kropf S; Gademann G; Ricke J
    PLoS One; 2014; 9(11):e112731. PubMed ID: 25393877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of radiation-induced liver toxicity after interstitial HDR brachytherapy by pentoxifylline and ursodeoxycholic acid: patient compliance and outcome in a randomized trial.
    Damm R; Wybranska J; Hass P; Walke M; Omari J; Pech M; Seidensticker R; Ricke J; Seidensticker M
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):9043-9049. PubMed ID: 37166579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases.
    Rühl R; Lüdemann L; Czarnecka A; Streitparth F; Seidensticker M; Mohnike K; Pech M; Wust P; Ricke J
    Radiat Oncol; 2010 May; 5():44. PubMed ID: 20507615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-induced liver damage: correlation of histopathology with hepatobiliary magnetic resonance imaging, a feasibility study.
    Seidensticker M; Burak M; Kalinski T; Garlipp B; Koelble K; Wust P; Antweiler K; Seidensticker R; Mohnike K; Pech M; Ricke J
    Cardiovasc Intervent Radiol; 2015 Feb; 38(1):213-21. PubMed ID: 24610229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary duct stenosis after image-guided high-dose-rate interstitial brachytherapy of central and hilar liver tumors : A systematic analysis of 102 cases.
    Powerski M; Penzlin S; Hass P; Seidensticker R; Mohnike K; Damm R; Steffen I; Pech M; Gademann G; Ricke J; Seidensticker M
    Strahlenther Onkol; 2019 Mar; 195(3):265-273. PubMed ID: 30470846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes.
    Seidensticker M; Seidensticker R; Mohnike K; Wybranski C; Kalinski T; Luess S; Pech M; Wust P; Ricke J
    Radiat Oncol; 2011 Apr; 6():40. PubMed ID: 21496320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation.
    Ricke J; Wust P; Wieners G; Beck A; Cho CH; Seidensticker M; Pech M; Werk M; Rosner C; Hänninen EL; Freund T; Felix R
    J Vasc Interv Radiol; 2004 Nov; 15(11):1279-86. PubMed ID: 15525748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases.
    Wybranski C; Zeile M; Löwenthal D; Fischbach F; Pech M; Röhl FW; Gademann G; Ricke J; Dudeck O
    Radiat Oncol; 2011 Apr; 6(1):43. PubMed ID: 21524305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer.
    Wazer DE; Lowther D; Boyle T; Ulin K; Neuschatz A; Ruthazer R; DiPetrillo TA
    Int J Radiat Oncol Biol Phys; 2001 May; 50(1):107-11. PubMed ID: 11316552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of metastatic, imatinib refractory, gastrointestinal stroma tumor with image-guided high-dose-rate interstitial brachytherapy.
    Omari J; Drewes R; Matthias M; Mohnike K; Seidensticker M; Seidensticker R; Streitparth T; Ricke J; Powerski M; Pech M
    Brachytherapy; 2019; 18(1):63-70. PubMed ID: 30385116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation.
    Ricke J; Seidensticker M; Lüdemann L; Pech M; Wieners G; Hengst S; Mohnike K; Cho CH; Lopez Hänninen E; Al-Abadi H; Felix R; Wust P
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):776-84. PubMed ID: 15936559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma.
    Walter F; Nierer L; Rottler M; Duque AS; Weingandt H; Well J; Shpani R; Landry G; Seidensticker M; Streitparth F; Ricke J; Belka C; Corradini S
    Radiat Oncol; 2021 May; 16(1):86. PubMed ID: 33957941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum proinflammatory cytokine response in patients with advanced liver tumors following selective internal radiation therapy (SIRT) with (90)Yttrium microspheres.
    Wickremesekera JK; Chen W; Cannan RJ; Stubbs RS
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1015-21. PubMed ID: 11240242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early results of pulsed-dose-rate interstitial brachytherapy for head and neck malignancies after limited surgery.
    Strnad V; Lotter M; Grabenbauer G; Sauer R
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):27-30. PubMed ID: 10656368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A murine model for the study of molecular pathogenesis of radiation proctitis.
    Symon Z; Goldshmidt Y; Picard O; Yavzori M; Ben-Horin S; Alezra D; Barshack I; Chowers Y
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):242-50. PubMed ID: 20005457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.